iRhythm (IRTC) News
NASDAQ: IRTCHealth CareMedical/Dental InstrumentsUSD
94.72+0.48 (+0.51%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
IRTC news summary
We found 22 recent headlines mentioning iRhythm (IRTC): 5 in the past week and 15 in the past 30 days, most often from Nasdaq, GlobeNewswire, Seeking Alpha. For price context, IRTC is up 0.51% at $94.72. The most recent story, "Friday 11/20 Insider Buying Report: IRTC, PLD", was published by Nasdaq on Nov 20, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest iRhythm headlines
- Friday 11/20 Insider Buying Report: IRTC, PLDAs the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On…NasdaqIRTC, PLD
- IRhythm Signs $100 Mln Accelerated Share Buyback Agreement With JPMorgan(RTTNews) - iRhythm Holdings, Inc. (IRTC) said Tuesday it entered into a $100 million accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank, National Association, under its previously…NasdaqIRTC, JPM, BF.A
- iRhythm Technologies, Inc. Enters into $100.0 million Accelerated Share Repurchase AgreementOn November 17, 2026, iRhythm Technologies, Inc. entered into an accelerated share repurchase agreement with JPMorgan Chase Bank, National Association to repurchase an aggregate of $100.0 million of…Nasdaq
- iRhythm kicks off $100M accelerated share repurchase deal with JPMorganSeeking Alpha
- iRhythm Announces $100 Million Accelerated Share Repurchase AgreementSAN FRANCISCO, Nov. 17, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (Nasdaq: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and…GlobeNewswire
- BTIG sees upside across medtech stocks as iRhythm, Delcath and MiniMed stand outInvesting.comMMED, IRTC
- iRhythm Technologies, Inc. Announces $200.0 Million Share Repurchase ProgramiRhythm Technologies, Inc. announced that on November 10, 2026, its board of directors approved a share repurchase program with authorization to purchase up to $200.0 million of the outstanding…Nasdaq
- IRhythm Approves $200 Mln Share Buy-Back For Operational Expenses(RTTNews) - iRhythm Holdings, Inc. (IRTC) said its board approved a program to repurchase up to $200 million of outstanding common shares.NasdaqIRTC, LEN.B
- iRhythm Announces Approval of $200 Million Share Repurchase ProgramSAN FRANCISCO, Nov. 11, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (Nasdaq: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and…GlobeNewswire
- IRTC Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into iRhythm Technologies, Inc. (IRTC)A revenue shortfall against Wall Street consensus, flat Zio AT sales, and the Zio MCT FDA submission has now slipped into 2027. SueWallSt notifies investors of a pending investigation into potential…PR Newswire
- iRhythm plunges after Q3 miss, Zio MCT delaySeeking Alpha
- iRhythm Holdings to Participate in Upcoming Investor ConferencesSAN FRANCISCO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and…GlobeNewswire
- iRhythm (IRTC) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaqIRTC, HEI.A
- IRhythm plans Zio MCT FDA filing in 2027 while raising 2026 revenue outlook to $890M-$895MSeeking Alpha
- iRhythm Holdings Announces Third Quarter 2026 Financial ResultsSAN FRANCISCO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and…GlobeNewswire
- Here's How Tempus AI Demonstrates Improving Operating LeverageTEM shows improving operating leverage as Q2 revenues jump 22%, adjusted EBITDA turns positive and lower interest costs support its free cash flow goal.NasdaqTEM, IRTC, INSP
- iRhythm wins new Overweight at Piper on YTD pullbackSeeking Alpha
- iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026SAN FRANCISCO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent…GlobeNewswire
- Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be…PR Newswire
- Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?TEM's strong data licensing growth, AI-driven innovations and rising shares favor holding the stock, but premium valuation and reimbursement risks warrant caution.NasdaqTEM, IRTC, CTEV
- Here's How Tempus AI is Capitalizing on AI-ECG Market GrowthTEM is expanding its cardiovascular portfolio with FDA-cleared AI-ECG tools targeting complex cardiac conditions.NasdaqTEM, IRTC, GEHC
- Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?iRhythm's Q2 revenue growth, margin expansion and record free cash flow strengthen its case, but reimbursement and regulatory risks remain elevated.NasdaqIRTC, BSX, PHG